REGEN BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
REGEN BIOPHARMA, INC. (RGBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2021-03-31, per its 10-Q filed 2021-08-18.
Discontinued › Notes › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2021-08-18
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-12-31 was 0.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-12-31 was 0.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-12-31 was 0.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
- REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2018 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2021-03-31 | 0.00% 10-Q · filed 2021-08-18 | |||
| 2020-12-31 | 0.00% 10-Q · filed 2021-08-13 | |||
| 2020-09-30 | 0.00% 10-K · filed 2021-08-04 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | 0.00% 10-Q · filed 2021-08-05 | |||
| 2019-09-30 | 0.00% 10-K · filed 2021-06-21 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-10-24 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-08-29 | |||
| 2018-12-31 | 0.00% 10-Q · filed 2019-02-12 | |||
| 2018-09-30 | 0.00% 10-K · filed 2018-12-27 |